Hyundai Bioscience Co. Ltd
048410StockKQ
8,910.00 ▼ 1.87%
12 juin 2026
0
Hyundai Bioscience Co. Ltd
8,910.00 ▼ 1.87%
12 juin 2026
048410StockKQ

01 / À propos

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.

Arberion
Loading market data